NCT07391930 High-Intensity Interval Training and Menstrual Health Experience in Primary Dysmenorrhea.
| NCT ID | NCT07391930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alcala |
| Condition | Dysmenorrhea Primary |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-18 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-18 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate whether a 12-week online supervised high-intensity interval training program can reduce menstrual pain and improve quality of life in women with primary dysmenorrhea. Participants will be divided into two groups: one receiving an educational workshop and the HIIT program, and a control group receiving only the workshop. Additionally, the study seeks to understand the personal experience of these women through weekly health diaries, exploring how the intervention affects their relationship with their bodies and their menstruation. The ultimate goal is to offer new, non-pharmacological evidence-based tools for managing menstrual pain.
Eligibility Criteria
Inclusion Criteria: * nulliparous * primary dysmenorrhea * body mass index between 18 and 30 * menstrual pain \>5 according to the Numeric Pain Scale * exercise \>45 minutes/week * understand Spanish and can freely read and sign the informed consent form Exclusion Criteria: * amenorrhea or cycles \>35 days * secondary dysmenorrhea * pelvic or abdominal surgical intervention * use of hormonal drugs * diagnosed with fibromyalgia, muscoloskeletal injuries or medical comorbidities that prevent them from performing intense exercise * receiving physiotherapy for pelvic floor disorders * intense exercise \>75 minutes/week
Contact & Investigator
Beatriz Navarro Brazalez, PhD
STUDY DIRECTOR
Universidad de Alcala
Frequently Asked Questions
Who can join the NCT07391930 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Dysmenorrhea Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07391930 currently recruiting?
Yes, NCT07391930 is actively recruiting participants. Contact the research team at esther.pindado@edu.uah.es for enrollment information.
Where is the NCT07391930 trial being conducted?
This trial is being conducted at Alcalá de Henares, Spain.
Who is sponsoring the NCT07391930 clinical trial?
NCT07391930 is sponsored by University of Alcala. The principal investigator is Beatriz Navarro Brazalez, PhD at Universidad de Alcala. The trial plans to enroll 60 participants.